The OrganaBio Blog

The Supply Brain

Addressing supply chain challenges in cell and gene therapy

Developing a Robust CGT Manufacturing Process

In this presentation, OrganaBio’s Head of Process & Product Development highlights our approach to setting the stage early in process development for sustained manufacturing success. This talk was originally given at the 2020 Cell & Gene Therapy Bioprocessing & Commercialization global conference. The conference brought together 856 members of the cell and gene therapy community in an effort to stimulate collaborations and partnerships that accelerate the development of life-saving or life-altering therapies for patients in need.

Priya Baraniak, Ph.D.

Dr. Baraniak is a proven strategic thinker, problem solver and leader who brings 20 years of expertise in stem cells and tissue engineering, coupled with a keen business acumen, to OrganaBio. Dr. Baraniak has published multiple peer-reviewed papers and book chapters on the use of stem cells and biomaterials in cardiac repair and regeneration and is routinely invited to speak at conferences.